Supernus Pharmaceuticals Inc (SUPN)

Return on assets (ROA)

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income US$ in thousands -1 60,711 53,424 126,950 113,056
Total assets US$ in thousands 1 1,702,510 1,689,150 1,504,100 1,160,280
ROA -100.00% 3.57% 3.16% 8.44% 9.74%

December 31, 2023 calculation

ROA = Net income ÷ Total assets
= $-1K ÷ $1K
= -100.00%

Supernus Pharmaceuticals Inc's return on assets (ROA) has shown a declining trend over the past five years, dropping from 9.74% in 2019 to 0.10% in 2023. This indicates that the company's ability to generate profits from its assets has weakened significantly. The significant decrease in ROA may indicate operational inefficiencies, increased expenses, or a decrease in asset productivity. It is essential for the company to investigate the underlying reasons for the decline in ROA and implement strategies to improve asset utilization and profitability.


Peer comparison

Dec 31, 2023